L

Latigo Biotherapeutics Inc
D

LTGO

21.080
USD
-1.42
(-6.31%)
Post Trading·20.720USD-0.360(-1.71%)
حجم التداول
6,076
الربح لكل سهم
0
العائد الربحي
-
P/E
-11
حجم السوق
1,397,590,235
المقالات
المزيد

العنوان: Latigo Biotherapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.